<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font3" size="7" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font4" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="9" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font6" size="9" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font7" size="9" family="AkzidenzGroteskBE,BoldItalic" color="#000000"/>
	<fontspec id="font8" size="9" family="SymbolMT" color="#000000"/>
	<fontspec id="font9" size="11" family="AkzidenzGroteskBE,Bold" color="#000000"/>
<text top="42" left="56" width="199" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Breast Cancer Research Vol 8 No 6    Einarsdóttir et al.<b>Breast Cancer Research</b></text>
<text top="758" left="56" width="45" height="7" font="font1" id="p1_t2" reading_order_no="101" segment_no="15" tag_type="text">Page 6 of 12</text>
<text top="768" left="56" width="120" height="6" font="font3" id="p1_t3" reading_order_no="102" segment_no="16" tag_type="text">(page number not for citation purposes)<i>et al.</i></text>
<text top="85" left="56" width="241" height="9" font="font4" id="p1_t4" reading_order_no="1" segment_no="1" tag_type="text">was 2.9 kb in the ATM gene, 4.0 kb in the CHEK2 gene and</text>
<text top="97" left="56" width="240" height="9" font="font4" id="p1_t5" reading_order_no="2" segment_no="1" tag_type="text">2.8 kb in the ERBB2 gene. We detected strong LD across all<i>(page number not for citation purposes)</i></text>
<text top="109" left="56" width="240" height="9" font="font4" id="p1_t6" reading_order_no="3" segment_no="1" tag_type="text">three genes [supplementary Figure 1, Figure 1 in Einarsdóttir</text>
<text top="120" left="56" width="240" height="9" font="font4" id="p1_t7" reading_order_no="4" segment_no="1" tag_type="text">and colleagues [56] and supplementary figure 2, respectively].<i>ATM </i></text>
<text top="132" left="56" width="240" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="1" tag_type="text">Using the SNP dropping method [47], we found that the tag-</text>
<text top="144" left="56" width="240" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="1" tag_type="text">SNPs selected from the SNPs included in our study could<i>CHEK2 </i></text>
<text top="156" left="56" width="240" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="1" tag_type="text">capture nongenotyped SNPs as efficiently as the SNPs</text>
<text top="167" left="56" width="182" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="1" tag_type="text">included in our study (supplementary Table 1).</text>
<text top="191" left="56" width="94" height="8" font="font6" id="p1_t12" reading_order_no="9" segment_no="4" tag_type="title">Breast cancer survival<i>ERBB2 </i></text>
<text top="203" left="56" width="240" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="5" tag_type="text">Table 2 summarizes the information on the tagSNPs in the</text>
<text top="214" left="56" width="240" height="9" font="font5" id="p1_t14" reading_order_no="11" segment_no="5" tag_type="text">ATM, CHEK2 and ERBB2 genes that we genotyped in breast</text>
<text top="226" left="56" width="241" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="5" tag_type="text">cancer cases and controls. All of the tagSNPs in the CHEK2<a href="">d colleagues [56] and su</a>pplementary figure 2, respectively].</text>
<text top="238" left="56" width="241" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="5" tag_type="text">and ERBB2 genes and two of the tagSNPs in the ATM gene<a href="">[47]</a>, we found that the tag-</text>
<text top="250" left="56" width="240" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="5" tag_type="text">were not only genotyped in breast cancer cases and controls</text>
<text top="261" left="56" width="241" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="5" tag_type="text">who participated through blood sample donation, but were</text>
<text top="273" left="56" width="240" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="5" tag_type="text">also genotyped in breast cancer cases who participated<a href=""> 1)</a>.</text>
<text top="285" left="56" width="240" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="5" tag_type="text">through tissue sample donation. None of the tagSNPs devi-<b>Breast cancer survival</b></text>
<text top="297" left="56" width="240" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="5" tag_type="text">ated significantly from HWE among the controls or showed a<a href="">Table 2 su</a>mmarizes the information on the tagSNPs in the</text>
<text top="308" left="56" width="240" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="5" tag_type="text">meaningful association with known breast cancer risk factors.<i>ATM, CHEK2 </i></text>
<text top="320" left="56" width="240" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="5" tag_type="text">Only one of the tagSNPs – TAG5 (also named I655V) in the</text>
<text top="332" left="56" width="241" height="9" font="font5" id="p1_t24" reading_order_no="21" segment_no="5" tag_type="text">ERBB2 gene – conferred an amino acid change in the protein<i>ERBB2 </i></text>
<text top="344" left="56" width="33" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="5" tag_type="text">product.</text>
<text top="367" left="56" width="240" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="8" tag_type="text">We estimated the risk of death from breast cancer associated</text>
<text top="379" left="56" width="240" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="8" tag_type="text">with the tagSNPs (Table 2) in the ATM , CHEK2 and ERBB2<i>CHEK2</i></text>
<text top="391" left="56" width="240" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="8" tag_type="text">genes or their haplotypes (Table 3). We found a decreased</text>
<text top="402" left="56" width="240" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="8" tag_type="text">risk of death from breast cancer associated with each addition<i>ERBB2 </i></text>
<text top="414" left="56" width="241" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="8" tag_type="text">of the rare TAG2 allele in the CHEK2 gene ( P = 0.026) and</text>
<text top="426" left="56" width="240" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="8" tag_type="text">an elevated risk of death from breast cancer associated with<i>ATM </i></text>
<text top="438" left="56" width="241" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="8" tag_type="text">the rare TAG6 allele in the CHEK2 gene ( P = 0.03), compared</text>
<text top="449" left="56" width="241" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="8" tag_type="text">with homozygotes of the common allele for each variant. The</text>
<text top="461" left="56" width="240" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="8" tag_type="text">associations did not, however, withstand Bonferroni correc-</text>
<text top="473" left="56" width="241" height="9" font="font4" id="p1_t35" reading_order_no="32" segment_no="8" tag_type="text">tion. Carriers of haplotype 2 in the CHEK2 gene seemed to</text>
<text top="485" left="56" width="241" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="8" tag_type="text">have a decreased risk of death from breast cancer ( P = 0.038)</text>
<text top="496" left="56" width="241" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="8" tag_type="text">compared with haplotype 1 carriers, whereas carriers of the</text>
<text top="508" left="56" width="241" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="8" tag_type="text">rare ERBB2 haplotypes seemed to have an increased risk of</text>
<text top="520" left="56" width="241" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="8" tag_type="text">death from breast cancer ( P = 0.009). Neither association car-</text>
<text top="532" left="56" width="240" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="8" tag_type="text">ried over to the global test ( P = 0.15 and P = 0.45,<i>ERBB2 </i></text>
<text top="543" left="56" width="51" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="8" tag_type="text">respectively).</text>
<text top="567" left="56" width="241" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="11" tag_type="text">We noticed in Table 3 that all of the ATM haplotypes con-</text>
<text top="579" left="56" width="240" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="11" tag_type="text">ferred a decrease in risk of death from breast cancer com-</text>
<text top="590" left="56" width="241" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="11" tag_type="text">pared with haplotype 1. We therefore assessed the<a href="">with the tagSNPs (Table 2) </a>in the </text>
<text top="602" left="56" width="240" height="9" font="font4" id="p1_t45" reading_order_no="42" segment_no="11" tag_type="text">association of haplotype 1 with the risk of death from breast<i>ATM</i></text>
<text top="614" left="56" width="240" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="11" tag_type="text">cancer and found a nonsignificantly elevated risk compared</text>
<text top="626" left="56" width="241" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="11" tag_type="text">with noncarriers [odds ratio (OR), 1.13; 95% confidence inter-<i>CHEK2 </i></text>
<text top="637" left="56" width="80" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="11" tag_type="text">val (CI), 0.92–1.40].</text>
<text top="661" left="56" width="98" height="8" font="font6" id="p1_t49" reading_order_no="46" segment_no="13" tag_type="title">Tumour characteristics<i>ERBB2</i></text>
<text top="673" left="56" width="241" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="14" tag_type="text">We calculated global P values for the association between the<a href="">able 3).</a> We found a decreased</text>
<text top="684" left="56" width="241" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="14" tag_type="text">tagSNP haplotypes in the ATM , CHEK2 and ERBB2 genes</text>
<text top="696" left="56" width="240" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="14" tag_type="text">and the risk of tumour-characteristic-defined breast cancer</text>
<text top="708" left="56" width="240" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="14" tag_type="text">from logistic regression models. Cases were divided into<i>CHEK2 </i></text>
<text top="720" left="56" width="241" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="14" tag_type="text">groups according to their tumour characteristics and each</text>
<text top="85" left="315" width="240" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="2" tag_type="text">group contrasted against all controls. Each logistic regression<i>P </i></text>
<text top="97" left="315" width="240" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="2" tag_type="text">model included the common haplotypes and the combined</text>
<text top="109" left="315" width="240" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="2" tag_type="text">group of rare haplotypes, with the most common haplotype</text>
<text top="120" left="315" width="241" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="2" tag_type="text">used as a reference standard. None of the global P values</text>
<text top="132" left="315" width="240" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="2" tag_type="text">reached significance (supplementary Table 4), which indi-<i>CHEK2 </i></text>
<text top="144" left="315" width="240" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="2" tag_type="text">cates that none of the individual haplotypes affected the risk of</text>
<text top="156" left="315" width="187" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="2" tag_type="text">developing tumours with certain characteristics.<i>P </i></text>
<text top="179" left="315" width="240" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="3" tag_type="text">We genotyped the CHEK2 1100delC gene mutation in our</text>
<text top="191" left="315" width="240" height="9" font="font4" id="p1_t63" reading_order_no="60" segment_no="3" tag_type="text">study population and have previously reported its effect on the</text>
<text top="203" left="315" width="240" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="3" tag_type="text">overall risk of breast cancer [56]. The deletion was very rare in</text>
<text top="214" left="315" width="240" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="3" tag_type="text">our study population, with a frequency of 0.7% among the</text>
<text top="226" left="315" width="240" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="3" tag_type="text">cases and 0.4% among the controls. We could therefore not<i>CHEK2 </i></text>
<text top="238" left="315" width="240" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="3" tag_type="text">perform a meaningful analysis of the association between the</text>
<text top="250" left="315" width="240" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="3" tag_type="text">deletion and breast cancer characteristics or survival in the</text>
<text top="261" left="315" width="54" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="3" tag_type="text">current study.<i>P </i></text>
<text top="285" left="315" width="240" height="8" font="font6" id="p1_t70" reading_order_no="67" segment_no="6" tag_type="title">Overall risk of breast cancer: the ATM and ERBB2 genes</text>
<text top="297" left="315" width="240" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="7" tag_type="text">We found no effect of the ATM or ERBB2 tagSNPs (supple-</text>
<text top="308" left="315" width="240" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="7" tag_type="text">mentary Table 5) or haplotypes (supplementary Table 6) on</text>
<text top="320" left="315" width="240" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="7" tag_type="text">the overall risk of breast cancer, which was not altered after<i>ERBB2 </i></text>
<text top="332" left="315" width="240" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="7" tag_type="text">conditioning on the selection variables (menopausal hormone</text>
<text top="344" left="315" width="240" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="7" tag_type="text">therapy and diabetes mellitus) or restricting the analyses to the</text>
<text top="355" left="315" width="241" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="7" tag_type="text">randomly selected cases and controls. Stratifying the haplo-<i>P </i></text>
<text top="367" left="315" width="240" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="7" tag_type="text">type results by known breast cancer risk factors did not yield</text>
<text top="379" left="315" width="232" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="7" tag_type="text">any additional compelling findings (supplementary Table 7).</text>
<text top="402" left="315" width="240" height="9" font="font4" id="p1_t79" reading_order_no="76" segment_no="9" tag_type="text">We genotyped two mis-sense mutations in the ATM gene in<i>P </i></text>
<text top="411" left="315" width="240" height="12" font="font4" id="p1_t80" reading_order_no="77" segment_no="9" tag_type="text">the complete sample set: 4258 C → T (rs1800058; L1420F)</text>
<text top="423" left="315" width="240" height="12" font="font4" id="p1_t81" reading_order_no="78" segment_no="9" tag_type="text">and 2572 T → C (rs1800056; F858L). Neither mutation devi-<i>P </i></text>
<text top="438" left="315" width="240" height="9" font="font4" id="p1_t82" reading_order_no="79" segment_no="9" tag_type="text">ated significantly from HWE in controls. They were both rare</text>
<text top="449" left="315" width="240" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="9" tag_type="text">in our study population, with a minor allele frequency of 1.9%</text>
<text top="458" left="315" width="240" height="12" font="font4" id="p1_t84" reading_order_no="81" segment_no="9" tag_type="text">for 4258 C → T and 1.4% for 2527 T → C in the controls. In<a href=""> noticed in Table 3 that all of the </a></text>
<text top="473" left="315" width="240" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="9" tag_type="text">exploring the change in the risk of breast cancer with each<i>ATM </i></text>
<text top="485" left="315" width="240" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="9" tag_type="text">addition of the rare allele compared with noncarriers (assum-</text>
<text top="496" left="315" width="240" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="9" tag_type="text">ing co-dominance), an elevated – but not significant – risk for</text>
<text top="505" left="315" width="240" height="12" font="font4" id="p1_t88" reading_order_no="85" segment_no="9" tag_type="text">the 4258 C → T (OR, 1.36; 95% CI, 0.91–2.04) was found,</text>
<text top="517" left="315" width="240" height="12" font="font4" id="p1_t89" reading_order_no="86" segment_no="9" tag_type="text">but no association emerged between the 2527 T → C and the</text>
<text top="532" left="315" width="209" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="9" tag_type="text">risk of breast cancer (OR, 1.05; 95% CI, 0.65–1.71).</text>
<text top="555" left="315" width="57" height="10" font="font9" id="p1_t91" reading_order_no="88" segment_no="10" tag_type="title">Discussion</text>
<text top="567" left="315" width="240" height="9" font="font4" id="p1_t92" reading_order_no="89" segment_no="12" tag_type="text">Although the gene products of ATM, CHEK2 and ERBB2 are</text>
<text top="579" left="315" width="240" height="9" font="font4" id="p1_t93" reading_order_no="90" segment_no="12" tag_type="text">involved in various aspects of breast cancer development and<b>Tumour characteristics</b></text>
<text top="590" left="315" width="240" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="12" tag_type="text">progression, our results suggest that common variation in</text>
<text top="602" left="315" width="240" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="12" tag_type="text">these genes does not affect survival, tumour-characteristic-<i>P </i></text>
<text top="614" left="315" width="240" height="9" font="font4" id="p1_t96" reading_order_no="93" segment_no="12" tag_type="text">defined risk or the overall risk of breast cancer. We carefully</text>
<text top="626" left="315" width="240" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="12" tag_type="text">studied these associations, both overall and in subgroups of</text>
<text top="637" left="315" width="240" height="9" font="font4" id="p1_t98" reading_order_no="95" segment_no="12" tag_type="text">known nongenetic breast cancer risk factors, using large pop-<i>ATM</i></text>
<text top="649" left="315" width="240" height="9" font="font4" id="p1_t99" reading_order_no="96" segment_no="12" tag_type="text">ulation-based case–control material, and conclude that on the</text>
<text top="661" left="315" width="240" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="12" tag_type="text">population level, common genetic variation in these genes is<i>CHEK2 </i></text>
<text top="673" left="315" width="240" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="12" tag_type="text">not of great importance for these outcomes. This does not pre-</text>
<text top="684" left="315" width="241" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="12" tag_type="text">clude the possibility that more crucial – and rare – variation is<i>ERBB2 </i></text>
<text top="696" left="315" width="144" height="9" font="font4" id="p1_t103" reading_order_no="100" segment_no="12" tag_type="text">influential in selected patient groups.</text>
</page>
</pdf2xml>
